A black male runner at the starting line of a race, waiting in crouch position against the background of the running track in a shape of an antibody. A black male runner at the starting line of a race, waiting in crouch position against the background of the running track in a shape of an antibody.

Vectibix
is an anti-neoplastic
agent used in treatment
of non-mutated (wild-type)
RAS metastatic colorectal
carcinoma (mCRC)

mid-bg

Vectibix (panitumumab for injection) is indicated for the treatment of previously untreated patients
with non-mutated (wild-type) RAS metastatic colorectal carcinoma (mCRC) in combination with
FOLFOX (infusional 5-fluorouracil, leucovorin, and oxaliplatin).

Vectibix is indicated as monotherapy for the treatment of patients with non-mutated (wild-type) RAS mCRC after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

  • A smiling, middle-aged white woman with grey hair.
    Learn about the VICTORY
    Patient Assistance Program by Amgen Entrust®
    Patient Support Services*

    * Amgen Entrust is our unified patient services platform built on the legacy of our branded support program.

Send your patients a personalized starter kit with everything they need to get started with Vectibix.
FOLFOX, infusional 5-fluorouracil, leucovorin, and oxaliplatin; mCRC, metastatic colorectal carcinoma; RAS, Rat sarcoma viral oncogene homologue.